Who
David Michael Williams
EVP,Chief Info&Digital Officer
Company insider
Files Form 4 as: EVP,Chief Info&Digital Officer, Merck & Company.
In numbers
- Trades disclosed
- 84
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $17.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Feb 2021
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $357K4,600 at $77.62 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $592K4,600 at $128.77 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $1.0M13,542 at $75.36 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,600 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —13,542 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,705 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.7M13,542 at $128.77 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $2.6M34,705 at $73.73 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $4.5M34,705 at $128.77 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,600 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —13,542 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,705 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $357K4,600 at $77.62 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $592K4,600 at $128.77 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $1.0M13,542 at $75.36 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.7M13,542 at $128.77 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Code M | $2.6M34,705 at $73.73 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $4.5M34,705 at $128.77 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,640 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —13,582 at $0.00 | filing |
News
Moderna, Merck shares fall on eagerly anticipated cancer vaccine resultsMRK · biopharmadive.com · 22 Oct 2026Merck & Co., Inc. $MRK Stock Sold by Smith Chas P & Associates PA CpasMRK · dailypolitical.com · 22 Oct 2026Merck's KEYTRUDA Plus Padcev Wins EU Approval For Muscle-Invasive Bladder CancerMRK · rttnews.com · 21 Oct 2026
0 headlines in the last 90 days name David Michael Williams; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.